Based on the key indicators related to Roivant Sciences' liquidity, profitability, solvency, and operating efficiency, Roivant Sciences is doing better financially today then in previous quarter. It has a moderate odds of reporting better financial numbers in April. At this time, Roivant Sciences' Net Receivables is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 8.7 B in 2025, whereas Other Current Liabilities is likely to drop slightly above 166.2 M in 2025. Key indicators impacting Roivant Sciences' financial strength include:
The essential information of the day-to-day investment outlook for Roivant Sciences includes many different criteria found on its balance sheet. An individual investor should monitor Roivant Sciences' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Roivant Sciences.
Please note, the imprecision that can be found in Roivant Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Roivant Sciences. Check Roivant Sciences' Beneish M Score to see the likelihood of Roivant Sciences' management manipulating its earnings.
Roivant Sciences Stock Summary
Roivant Sciences competes with Krystal Biotech, Akero Therapeutics, Apellis Pharmaceuticals, Day One, and Phathom Pharmaceuticals. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Roivant Sciences' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Roivant Sciences's current stock value. Our valuation model uses many indicators to compare Roivant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roivant Sciences competition to find correlations between indicators driving Roivant Sciences's intrinsic value. More Info.
Roivant Sciences is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Roivant Sciences' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Roivant Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Roivant Sciences Systematic Risk
Roivant Sciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Roivant Sciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Roivant Sciences correlated with the market. If Beta is less than 0 Roivant Sciences generally moves in the opposite direction as compared to the market. If Roivant Sciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Roivant Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Roivant Sciences is generally in the same direction as the market. If Beta > 1 Roivant Sciences moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Roivant Sciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Roivant Sciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Roivant Sciences growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Roivant Sciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Roivant Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Roivant Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Roivant Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Roivant Sciences's daily price indicators and compare them against related drivers.
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.